Stay updated on Aducanumab for Early Alzheimer's: Clinical Trial
Sign up to get notified when there's something new on the Aducanumab for Early Alzheimer's: Clinical Trial page.

Latest updates to the Aducanumab for Early Alzheimer's: Clinical Trial page
- Check4 days agoChange DetectedA new reference to a 2025 publication by Cummings et al. evaluating cognitive, functional, and behavioral effects observed in EMERGE (the aducanumab Phase 3 trial) was added to the Publications section.SummaryDifference0.0%

- Check11 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4, signaling a minor update to the page.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe entry for Malmö, Sweden, 20502 replaces the earlier Malmo, Sweden, 20502 in the Contacts and Locations section. This corrects the city name spelling and adds the proper diacritic.SummaryDifference0.0%

- Check33 days agoChange DetectedThe page’s displayed site/interface revision number was updated from v3.5.0 to v3.5.3, reflecting a change to the platform version rather than the study record content.SummaryDifference0.0%

- Check68 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. This appears to be a minor revision-tracking update and does not change the study details.SummaryDifference0.0%

- Check83 days agoChange DetectedRevision: v3.4.3 updated, replacing the previous v3.4.2.SummaryDifference0.0%

Stay in the know with updates to Aducanumab for Early Alzheimer's: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Aducanumab for Early Alzheimer's: Clinical Trial page.